MTS Medication (MTSI) Agrees To Be Acquired For $5.75/Share
MTS Medication Technologies, Inc. (NASDAQ: MTSI) entered into a definitive merger agreement to be acquired for $5.75 per share in cash by an affiliate of Excellere Partners, LLC, a Denver, Colorado based private equity firm.
MTSI closed at $5.70 per share on Friday.
Following the unanimous recommendation and approval of a Special Committee of independent directors, the full Board of Directors of MTS has approved the merger agreement and has recommended to the Company's stockholders that they adopt and approve the merger agreement.
Under the terms of the merger agreement, 100% of the issued and outstanding common stock of MTS will be acquired by Excellere Partners' newly formed affiliate, MedPak Holdings, Inc., in exchange for the per share cash consideration, or, with respect to a portion of the shares held by Todd E. Siegel, the Company's President and Chief Executive Officer, and certain other members of the Company's senior management team, shares of capital stock of MedPak Holdings.
MTSI closed at $5.70 per share on Friday.
Following the unanimous recommendation and approval of a Special Committee of independent directors, the full Board of Directors of MTS has approved the merger agreement and has recommended to the Company's stockholders that they adopt and approve the merger agreement.
Under the terms of the merger agreement, 100% of the issued and outstanding common stock of MTS will be acquired by Excellere Partners' newly formed affiliate, MedPak Holdings, Inc., in exchange for the per share cash consideration, or, with respect to a portion of the shares held by Todd E. Siegel, the Company's President and Chief Executive Officer, and certain other members of the Company's senior management team, shares of capital stock of MedPak Holdings.
You May Also Be Interested In
- UPDATE: RR Donnelley (RRD) to Buy Edgar Online (EDGR) for $70.5M
- Barclays Maintains an 'Overweight' on CVS Caremark (CVS); Positive on Shares After Mee ing
- 3D Systems Corporation (DDD) Acquires Bespoke Innovations; Affirms Outlook
Create E-mail Alert Related Categories
Mergers and AcquisitionsRelated Entities
Excellere PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
